Aralez Pharmaceuticals Inc. 4
4 · Aralez Pharmaceuticals Inc. · Filed Mar 18, 2016
Insider Transaction Report
Form 4
Glickman Mark A
Chief Commercial Officer
Transactions
- Award
Stock Options (right to buy)
2016-03-17+38,559→ 38,559 totalExercise: $3.80Exp: 2026-03-17→ Common Shares, without par value (38,559 underlying) - Award
Common Shares, without par value
2016-03-17+45,553→ 161,553 total
Footnotes (2)
- [F1]Restricted Stock Units granted pursuant to the Aralez Pharmaceuticals Inc. 2016 Long-Term Incentive Plan, which vest ratably over three years commencing on the anniversary of the date-of-grant.
- [F2]The options vest in equal tranches on a monthly basis over a 4-year period beginning on April, 17, 2016.